A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients (2009)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; MACHADO, ALCYONE ARTIOLI - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1038/tpj.2009.13
- Subjects: POLIMORFISMO; METALOPROTEINASES; SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA (TERAPIA); FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 9, n. 4, p. 265-273, 2009
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DEMACQ, Caroline et al. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, v. 9, n. 4, p. 265-273, 2009Tradução . . Disponível em: https://doi.org/10.1038/tpj.2009.13. Acesso em: 03 out. 2024. -
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Machado, A. A., & Santos, J. E. T. dos. (2009). A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, 9( 4), 265-273. doi:10.1038/tpj.2009.13 -
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients [Internet]. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273.[citado 2024 out. 03 ] Available from: https://doi.org/10.1038/tpj.2009.13 -
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients [Internet]. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273.[citado 2024 out. 03 ] Available from: https://doi.org/10.1038/tpj.2009.13 - Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects
- Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 MMP-9 activities
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
Informações sobre o DOI: 10.1038/tpj.2009.13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
